Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer.
Finelli A, Trottier G, Lawrentschuk N, Sowerby R, Zlotta AR, Radomski L, Timilshina N, Evans A, van der Kwast TH, Toi A, Jewett MA, Trachtenberg J, Fleshner NE.
Finelli A, et al. Among authors: timilshina n.
Eur Urol. 2011 Apr;59(4):509-14. doi: 10.1016/j.eururo.2010.12.018. Epub 2010 Dec 28.
Eur Urol. 2011.
PMID: 21211899